A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

被引:0
|
作者
Véronique Diéras
Jean Paul Guastalla
Jean Marc Ferrero
Hervé Curé
Béatrice Weber
Philippe Winckel
Alain Lortholary
Françoise Mayer
Désiré Paraiso
Emmanuelle Magherini
Eric Pujade-Lauraine
机构
[1] Institut Curie,Department of Medical Oncology
[2] Centre Léon Bérard,undefined
[3] Centre Antoine Lacassagne,undefined
[4] Centre Jean Perrin,undefined
[5] Centre Alexis Vautrin,undefined
[6] Clinique du Mail,undefined
[7] Centre Paul Papin,undefined
[8] Centre Georges François Leclerc,undefined
[9] CHU Hôtel-Dieu,undefined
[10] Laboratoire Aventis,undefined
来源
关键词
Docetaxel; Cisplatin; Ovarian cancer; Taxanes; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:489 / 495
页数:6
相关论文
共 50 条
  • [41] Cetuximab plus docetaxel-cisplatin (DC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase II study
    Fahlke, J.
    Ridwelski, K.
    Florschuetz, A.
    Kettner, E.
    Leithaeuser, M.
    Kroehning, H.
    Stuebs, P.
    Zierau, K.
    Lippert, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer
    Georgoulias, V
    Androulakis, N
    Bouros, D
    Kouroussis, C
    Chatzakis, K
    Papadakis, M
    Apostopoloulou, F
    Georgepoulou, T
    Kotsakis, T
    Souklakos, J
    Hatzidaki, D
    Vlachonikolis, J
    Panagos, G
    [J]. LUNG CANCER, 1998, 21 (03) : 213 - 220
  • [43] Modified Docetaxel-cisplatin in Combination with Capecitabine as First-line Treatment in Metastatic Gastric Cancer. A Phase II Study
    Polyzos, Aristides
    Felekouras, Evangellos
    Karatzas, Theodore
    Griniatsos, John
    Dimitroulis, Dimitrios
    Polyzos, Kostas
    Kontzoglou, Kostas
    Mantas, Dimitrios
    Karavokyros, John
    Nikiteas, Nikolaos
    Tsavaris, Nikolas
    Syrigos, Kostas
    Vafiadis, Irene
    [J]. ANTICANCER RESEARCH, 2012, 32 (09) : 4151 - 4156
  • [44] Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: A Hellenic Cooperative Oncology Group phase II study
    Papakostas P.
    Tsavdaridis D.
    Kosmidis P.
    Kalofonos H.P.
    Sakantamis A.
    Janinis D.
    Skarlos D.
    Bafaloukos D.
    Bamias A.
    Xiros N.
    Fountzilas G.
    [J]. Gastric Cancer, 2006, 9 (1) : 26 - 31
  • [45] Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer
    Friedlander, M.
    Buck, M.
    Wyld, D.
    Findlay, M.
    Fitzharris, B.
    De Souza, P.
    Davies, T.
    Kalimi, G.
    Allan, S.
    Perez, D.
    Harnett, P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (02) : 350 - 358
  • [46] Cisplatin and weekly docetaxel as first-line therapy in patients with advanced non-small cell lung cancer a phase II study
    Tartarone, A
    Romano, G
    Iodice, G
    Capobianco, A
    Coccaro, M
    Bochicchio, A
    Di Leo, P
    Ardito, R
    Di Renzo, N
    [J]. TUMORI, 2005, 91 (02) : 131 - 134
  • [48] Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy
    Zhang, Sheng
    Zhu, Yao
    Ye, Dingwei
    [J]. ONCOTARGET, 2015, 6 (31) : 32212 - 32219
  • [49] Phase II study with Docetaxel (Taxotere) as second line treatment of advanced soft tissues sarcomas in adult
    Verusio, C
    Romanini, A
    Frustaci, S
    Comandone, A
    DeToma, D
    Dogliotti, L
    Piolini, M
    Lionetto, R
    Dani, C
    Santoro, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 507 - 507
  • [50] Docetaxel and cisplatin as first-line treatment for patients with metastatic esophageal cancer:: A pilot study
    Laack, E
    Andritzky, B
    Dürk, H
    Burkholder, I
    Edler, L
    Schuch, G
    Boeters, I
    Görn, M
    Lipp, R
    Horst, H
    Popp, J
    Hossfeld, DK
    [J]. ONKOLOGIE, 2005, 28 (12): : 647 - 650